FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
12/14/2024
Back to search
Official data from USPTO
SYNKLINO
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
SYNKLINO
ST13
US500000079371712Class
5, 10, 42
Filing
79371712
Registration
7410895
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
12/14/2024
Trademark type
Word
Nice classes
5, 10, 42
Filing date
01/06/2023
Registration date
06/11/2024
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/11/2024
Last transaction
06/11/2024
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
DK
Examiner
RENNEKER, CHRISTOPHER
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
SYNKLINO A/S
Representatives
Howard W. Kline Nath, Goldberg & Meyer
Technical classification
Nice Classes
Class 5Class 10Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceutical preparations for the prevention of chronic viral infections in high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for regulating the immune system for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations for use in organ transplantation for elimination of chronic viral infections; pharmaceutical preparations for the prevention of diseases of the immune system; immunosuppressants for use following transplantation to prevent graft rejection; pharmaceutical preparations for the treatment of immune system related diseases and disorders; immunotherapeutic agents for treatment of bacterial infections; pharmaceutical preparations for immunity adjustment for high-risk immunocompromised patients and transplant recipients; pharmaceutical preparations containing stem cells for high-risk immunocompromised patients and transplant recipients; immunoassay reagents for medical use; pharmaceutical preparations for the treatment of viral diseases; anti-viral agents; protein synthesis inhibitors for high-risk immunocompromised patients and transplant recipients; regulatory proteins being pharmaceutical preparations for medical use for high-risk immunocompromised patients and transplant recipients; pharmaceutical drugs for high-risk immunocompromised patients and transplant recipients; antibacterial pharmaceuticals
Class 10
Surgical apparatus and instruments for medical use; medical diagnostic test instruments for use in immunoanalytical procedures; medical diagnostic testing apparatus for use in medical immunoassay procedures; medical devices for regenerating stem cells for medical purposes; medical apparatus for cell sampling; pharmaceutical instruments and apparatus provided empty used for the inhalation of pharmaceuticals
Class 42
Scientific research; scientific laboratory services; scientific research into stem cells; culturing of cells for scientific research purposes; scientific and medical research services for research and development in the field of immunology; pharmaceutical research; development of pharmaceutical preparations; pharmaceutical research and development services; development of pharmaceutical preparations and medications; carrying out clinical trials for pharmaceutical products; laboratory research on pharmaceutical preparations; consultancy in the field of drug research and development; software as a service (SAAS) services featuring software for gatheringtrackinganalyzing and activating data in relation to transformative therapies for high-risk immunocompromised patients and transplant recipients
Publications
History of USPTO decisions and trademark events.
23 publications found
FICS
FINAL DISPOSITION NOTICE SENT TO IB
11/22/2024
FIMP
FINAL DISPOSITION PROCESSED
11/22/2024
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/11/2024
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/11/2024
R.PR
REGISTERED-PRINCIPAL REGISTER
06/11/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/26/2024
PUBO
PUBLISHED FOR OPPOSITION
03/26/2024
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/06/2024
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/06/2024
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/20/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/19/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/19/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/19/2024
RFNT
REFUSAL PROCESSED BY IB
11/13/2023
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
10/24/2023
RFRR
REFUSAL PROCESSED BY MPU
10/24/2023
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
10/14/2023
CNRT
NON-FINAL ACTION WRITTEN
10/13/2023
DOCK
ASSIGNED TO EXAMINER
09/29/2023
MAFR
APPLICATION FILING RECEIPT MAILED
06/16/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
06/12/2023
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/08/2023
Continuous trademark protection
Get notified about every new filing that threatens SYNKLINO or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.